These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 22288903)

  • 1. Hypoxia regulation of ATP13A2 (PARK9) gene transcription.
    Xu Q; Guo H; Zhang X; Tang B; Cai F; Zhou W; Song W
    J Neurochem; 2012 Jul; 122(2):251-9. PubMed ID: 22288903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of ATP13A2 via PHD2-HIF1α Signaling Is Critical for Cellular Iron Homeostasis: Implications for Parkinson's Disease.
    Rajagopalan S; Rane A; Chinta SJ; Andersen JK
    J Neurosci; 2016 Jan; 36(4):1086-95. PubMed ID: 26818499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parkinson's disease-linked human PARK9/ATP13A2 maintains zinc homeostasis and promotes α-Synuclein externalization via exosomes.
    Kong SM; Chan BK; Park JS; Hill KJ; Aitken JB; Cottle L; Farghaian H; Cole AR; Lay PA; Sue CM; Cooper AA
    Hum Mol Genet; 2014 Jun; 23(11):2816-33. PubMed ID: 24603074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in the ATP13A2 gene and Parkinsonism: a preliminary review.
    Yang X; Xu Y
    Biomed Res Int; 2014; 2014():371256. PubMed ID: 25197640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of Thr12Met and Ala1144Thr mutations of the ATP13A2 gene in Parkinson's disease patients in Xinjiang Uygur and Han ethnic groups.
    Li G; Zhang Z; Xia H; Yang X
    Med Sci Monit; 2014 Nov; 20():2177-82. PubMed ID: 25374329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of ATP13A2 in Parkinson's disease: Clinical phenotypes and molecular mechanisms.
    Park JS; Blair NF; Sue CM
    Mov Disord; 2015 May; 30(6):770-9. PubMed ID: 25900096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. α-Synuclein-induced dopaminergic neurodegeneration in a rat model of Parkinson's disease occurs independent of ATP13A2 (PARK9).
    Daniel G; Musso A; Tsika E; Fiser A; Glauser L; Pletnikova O; Schneider BL; Moore DJ
    Neurobiol Dis; 2015 Jan; 73():229-43. PubMed ID: 25461191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysosomal defects in ATP13A2 and GBA associated familial Parkinson's disease.
    Sato S; Li Y; Hattori N
    J Neural Transm (Vienna); 2017 Nov; 124(11):1395-1400. PubMed ID: 28894968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ATP13A2 variability in Taiwanese Parkinson's disease.
    Chen CM; Lin CH; Juan HF; Hu FJ; Hsiao YC; Chang HY; Chao CY; Chen IC; Lee LC; Wang TW; Chen YT; Chen YT; Lee-Chen GJ; Wu YR
    Am J Med Genet B Neuropsychiatr Genet; 2011 Sep; 156B(6):720-9. PubMed ID: 21714071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parkinson's disease-associated ATP13A2/PARK9 functions as a lysosomal H
    Fujii T; Nagamori S; Wiriyasermkul P; Zheng S; Yago A; Shimizu T; Tabuchi Y; Okumura T; Fujii T; Takeshima H; Sakai H
    Nat Commun; 2023 Apr; 14(1):2174. PubMed ID: 37080960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutational analysis of GIGYF2, ATP13A2 and GBA genes in Brazilian patients with early-onset Parkinson's disease.
    Dos Santos AV; Pestana CP; Diniz KR; Campos M; Abdalla-Carvalho CB; de Rosso AL; Pereira JS; Nicaretta DH; de Carvalho WL; Dos Santos JM; Santos-Rebouças CB; Pimentel MM
    Neurosci Lett; 2010 Nov; 485(2):121-4. PubMed ID: 20816920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ATP13A2 Declines Zinc-Induced Accumulation of α-Synuclein in a Parkinson's Disease Model.
    Gao H; Sun H; Yan N; Zhao P; Xu H; Zheng W; Zhang X; Wang T; Guo C; Zhong M
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Parkinson-associated human P5B-ATPase ATP13A2 modifies lipid homeostasis.
    Marcos AL; Corradi GR; Mazzitelli LR; Casali CI; Fernández Tome MDC; Adamo HP; de Tezanos Pinto F
    Biochim Biophys Acta Biomembr; 2019 Oct; 1861(10):182993. PubMed ID: 31132336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Up-Regulation of Neuronal Nitric Oxide Synthase Expression by Cobalt Chloride Through a HIF-1α Mechanism in Neuroblastoma Cells.
    Li G; Zhao Y; Li Y; Lu J
    Neuromolecular Med; 2015 Dec; 17(4):443-53. PubMed ID: 26458913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hereditary Parkinsonism-Associated Genetic Variations in PARK9 Locus Lead to Functional Impairment of ATPase Type 13A2.
    Park JS; Sue CM
    Curr Protein Pept Sci; 2017; 18(7):725-732. PubMed ID: 26965689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ATP13A2 variability in Parkinson disease.
    Vilariño-Güell C; Soto AI; Lincoln SJ; Ben Yahmed S; Kefi M; Heckman MG; Hulihan MM; Chai H; Diehl NN; Amouri R; Rajput A; Mash DC; Dickson DW; Middleton LT; Gibson RA; Hentati F; Farrer MJ
    Hum Mutat; 2009 Mar; 30(3):406-10. PubMed ID: 19085912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ATP13A2 variants in early-onset Parkinson's disease patients and controls.
    Djarmati A; Hagenah J; Reetz K; Winkler S; Behrens MI; Pawlack H; Lohmann K; Ramirez A; Tadić V; Brüggemann N; Berg D; Siebner HR; Lang AE; Pramstaller PP; Binkofski F; Kostić VS; Volkmann J; Gasser T; Klein C
    Mov Disord; 2009 Oct; 24(14):2104-11. PubMed ID: 19705361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ATP13A2/PARK9 regulates endo-/lysosomal cargo sorting and proteostasis through a novel PI(3, 5)P2-mediated scaffolding function.
    Demirsoy S; Martin S; Motamedi S; van Veen S; Holemans T; Van den Haute C; Jordanova A; Baekelandt V; Vangheluwe P; Agostinis P
    Hum Mol Genet; 2017 May; 26(9):1656-1669. PubMed ID: 28334751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ATP13A2-mediated endo-lysosomal polyamine export counters mitochondrial oxidative stress.
    Vrijsen S; Besora-Casals L; van Veen S; Zielich J; Van den Haute C; Hamouda NN; Fischer C; Ghesquière B; Tournev I; Agostinis P; Baekelandt V; Eggermont J; Lambie E; Martin S; Vangheluwe P
    Proc Natl Acad Sci U S A; 2020 Dec; 117(49):31198-31207. PubMed ID: 33229544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A familial ATP13A2 mutation enhances alpha-synuclein aggregation and promotes cell death.
    Lopes da Fonseca T; Pinho R; Outeiro TF
    Hum Mol Genet; 2016 Jul; 25(14):2959-2971. PubMed ID: 27282395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.